Human Normal Immunoglobulin and Anti-D Immunoglobulin (CMU Call Off)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

This public procurement record has 1 release in its history.

Summary of the contracting process

The Common Services Agency, commonly known as NHS National Services Scotland (NSS), has successfully completed a public procurement process for a National Framework Agreement concerning the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. This agreement commenced on 1 July 2021, with a duration of 18 months and the potential for extensions totalling up to 48 months. The procurement, categorised under the health industry, was conducted through an open procedure, with contract awards completed in June 2021. The procurement activities were largely centred in Edinburgh, UK.

This tender presents significant opportunities for businesses involved in biotechnology and pharmaceuticals, particularly those supplying immunoglobulin products. Companies of various scales, including large suppliers and SMEs, are poised to benefit, especially those capable of delivering products to the Scottish National Blood Transfusion Service in Edinburgh. The comprehensive nature of this framework and the option for multiple awards suggest an ongoing demand for innovative solutions in the healthcare sector, inviting competitive bids for both existing and new business lines.

How relevant is this notice?

Notice Title

Human Normal Immunoglobulin and Anti-D Immunoglobulin (CMU Call Off)

Notice Description

National Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot Information

10% Intravenous Immunoglobulin (10% IVIg) - Existing Business

Supply of Human Normal Intravenous Immunoglobulin 10 %, across various vial sizes.

Subcutaneous Immunoglobulin (SCIg) - Existing Business

Supply of Human Normal Intravenous Immunoglobulin for subcutaneous use across various vial sizes

Facilitated Subcutaneous Immunoglobulin (fSCIg) - Existing Business

Supply of Subcutaneous Immunoglobulin with Hyaluronidase (Facilitated Subcutaneous Immunoglobulin)

10% Intravenous Immunoglobulin (10% IVIg) - New Business

Supply of Human Normal Intravenous Immunoglobulin 10 %, across various vial sizes for new patients.

Subcutaneous Immunoglobulin (SCIg) - New Business

Supply of Human Normal Intravenous Immunoglobulin for subcutaneous use across various vial sizes for new patients.

Facilitated Subcutaneous Immunoglobulin (fSCIg) - New Business

Supply of Subcutaneous Immunoglobulin with Hyaluronidase (Facilitated Subcutaneous Immunoglobulin) for new patients.

Anti-D Immunoglobulin (Anti-D)

Supply of Anti-D Immunoglobulin

5% Intravenous Immunoglobulin (5% IVIg) - Existing Business

Supply of Human Normal Intravenous Immunoglobulin 5 %, across various vial sizes.

5% Intravenous Immunoglobulin (5% IVIg) - New Business

Supply of Human Normal Intravenous Immunoglobulin 5 %, across various vial sizes for new patients.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000660005
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG425046
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
PCS Notice - Website Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33651520 - Immunoglobulins

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
23 Aug 20215 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
7
Supplier Names

Biotest (UK) Ltd

Bio Products Laboratory

CSL Behring UK Ltd

Grifols UK Ltd

LFB Biopharmaceuticals Ltd

Octapharma Limited

Takeda UK Ltd

Further Information

Notice Documents

  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG425046
    Human Normal Immunoglobulin and Anti-D Immunoglobulin (CMU Call Off) - National Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...